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Abstract 
Progress toward the synthesis of molecular beacons containing analogs of the universal 
quencher 4-(4'-dimethylaminophenylazo)benzoic acid (DABCYL) has been made. A 
synthetic methodology has been developed for the differential labeling of a PNA molecular 
beacon with quencher and fluorophore moieties. A DABCYL analog diarylazo compound 
and three small fluorescent molecules have been derivatized with terminal alkyne groups for 
incorporation into azide-decorated PNA oligomers by on-resin “click” chemistry. An 
optimized on-resin procedure was used to determine the viability of the fluorophores and 
quencher for incorporation into PNA. 
The synthesis of a pyrrolocytidine phosphoramidite containing a diarylazo DABCYL analog 
moiety was undertaken with the aim of incorporation into a DNA molecular beacon by 
standard phosphoramidite chemistry. While the phosphoramidite was not achieved, an 
unprecedented addition of the dimethoxytrityl protecting group to the electron-rich 
pyrrolocytidine heterocycle was observed and a mechanism for its formation is proposed. 
 
Keywords 
Nucleic acid, peptide nucleic acid, CuAAC, fluorescence, quencher, nucleoside analog, 
molecular beacons, DABCYL 
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Chapter 1 - Introduction 
1.1 Nucleic Acids  
Nucleic acids are the biomacromolecules that serve as template and repository for the genetic 
material of all living beings, from bacteria to plants to humans. Deoxyribonucleic acid (DNA) 
is the nucleic acid component of chromosomes, and codes for genes; ribonucleic acid (RNA), 
has myriad functions but is primarily known as the biopolymer that makes up the genetic 
transcripts that are translated into proteins.1 
 
Figure 1. The basic structures of deoxyribonucleic and ribonucleic acid nucleotides. 
The concept of “genes” as carriers of hereditary traits was first explored by Gregor Mendel in 
1865, but at that time the biochemical basis of genetic material and its reproduction was far 
from being understood. 2 The first major development in the discovery of nucleic acids came in 
1869. Johann Friedrich Miescher, a German physician working in the relatively new realm of 
“physiological chemistry”, had embarked on a project to elucidate the biochemical composition 
of cells by isolating leukocytes from pus in surgical bandages. In his attempts to isolate lipids 
and proteins from these cells, he encountered a substance that appeared to precipitate in acidic 
solution, then redissolve when basified. Elemental analysis of this substance identified it as 
distinct from both proteins and lipids in that it contained a high percentage of phosphorus. 
Miescher dubbed this substance “nuclein”, as he had isolated it from the nuclei of cells. 
However, Miescher’s published theories as to the purpose of “nuclein” touched only lightly on 
the possibility of its involvement in gene expression or cellular reproduction. 3 In 1889, Richard 
Altmann was able to isolate a sample of this material untainted by proteins. 4 Unaware that he 
had obtained a pure form of Miescher’s “nuclein”, 3 he recognized the acidic character of the 
substance and dubbed it Nucleinsäuren – nucleic acid. 
O
OH
HO
Base
O
OH
HO
Base
OH
2 
 
Later advancements in the nascent field of nucleic acid chemistry included the work of Albrecht 
Kossel, who identified the four compounds now known as the canonical DNA nucleobases: the 
purines, adenine and guanine, and the pyrimidines, cytosine and thymine.5 
 
Figure 2. The DNA nucleobases: adenine, guanine, cytosine, and thymine. 
Phoebus A. Levine further elucidated the components of “yeast nucleic acid”, as ribonucleic 
acid (RNA) was then known. 5 Via base hydrolysis of RNA he was able to identify the 
phosphate and sugar components. Levine also correctly described their connectivity, although 
he incorrectly asserted that nucleic acids formed in “tetranucleotides” – cyclic structures 
consisting of one of each of the four nucleotides joined covalently. 6 Finally, Erwin Chargaff 
was the first to recognize that in any given sample of DNA, the ratio of A:T and C:G bases 
remained constant. 7  
The elucidation of the structure of DNA is a relatively recent but profoundly important 
development in biochemistry. By the mid-twentieth century, the chromosomal nature of genes 
had been established but the scientific community was divided on whether the genetic material 
was carried by the nucleic acids or proteins found within chromosomes. A definitive structure 
for nucleic acids might provide an explanation for the problem of which macromolecule carried 
genes, and how said genes were replicated.  
James Watson and Francis Crick, at the University of Cambridge, applied themselves to the 
DNA structure problem in the early 1950s. It was not until Maurice Wilkins, a researcher at 
Kings College in London, showed them a photograph Wilkins’s colleague Rosalind Franklin 
had obtained of DNA that they were able to deduce the helical structure of the molecule. 8  
Watson and Crick also felt that the phosphates in DNA were found on the outside of the 
molecule. However, what eluded them at the time was an understanding of what held the two 
N
NNH
N
NH2
NH
NNH
N
O
NH2
N
N
H
NH2
O
NH
N
H
O
O
3 
 
strands together. Watson proposed that the nucleobases paired with themselves in the helix 
(adenine with adenine, for example). 8  
Watson and Crick consulted Jerry Donohue, a visiting chemist from Pauling’s lab, to determine 
the most stable tautomers of the nucleobases. On learning that the keto forms were most stable, 
and realizing that in these forms the bases could hydrogen bond with each other in A-T and G-
C purine-pyrimidine pairs, Watson and Crick were able to put the finishing touches on their 
model.8 
Watson and Crick published their proposed structure in the issue of Nature dated April 25, 1953 
– a single-page paper that modestly concludes: “It has not escaped our notice that the specific 
pairing we have postulated immediately suggests a copying mechanism for the genetic 
material.”9 
  
Figure 3. Watson and Crick's proposed structure for the DNA double helix, with detail showing 
the two antiparallel strands joined by hydrogen bonding between base pairs (G-C and A-T 
depicted). 
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Watson and Crick’s paper paved the way for further studies that established the supreme 
importance of nucleic acids in biological processes. Crick himself eventually formated a simple 
scheme that he described as the “central dogma of molecular biology”: 10  
 
Figure 4. The central dogma of molecular biology. 
Ultimately, nucleic acids are organic molecules, and as such can be synthesized, modified, and 
manipulated – a rich field of study that has been expanding ever since Francis Crick announced 
in the Eagle pub that he and his partner James Watson had “discovered the secret of life.” 
1.2 Hybridization Probes 
The extraordinary specificity and stability of hydrogen bonding interactions between purine and 
pyrimidine base pairs in nucleic acids, first elucidated by Watson and Crick, 9 is a much-studied 
facet of nucleic acid hybridization. The potential of this molecular recognition event in the 
design of probes to identify specific nucleotide sequences was realized as early as 1963, when 
radiolabeled RNA oligonucleotides were reported as a method to identify complementary 
sequences of DNA in samples. 11 Hybridization probes, as they are now known, would see a 
surge in interest and development over the next two decades, aided by such discoveries as 
endonuclease digestion of DNA. In 1975, Edward Southern’s report of a hybridization method 
to affix radiolabeled probes directly to digested DNA, known as a Southern blot, was among 
the most significant advances in this field. 11,12  
However, hybridization probe technology initially suffered from two major drawbacks. First, 
available methods for labeling probes – mostly involving radioactivity or fluorescence – did not 
provide a method for “turning off” the probes, requiring the removal of unhybridized probe 
from samples to prevent background signals. Second, this requirement also called for the 
hybridized nucleic acids to be immobilized on a membrane or other surface. These 
requirements precluded the use of hybridization probes to detect nucleic acid targets in real 
time, or in living cells. 
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1.3 Molecular Beacons 
A promising advance in the field of hybridization probes came in 1996, when Tyagi and 
Kramer published a report of a novel hybridization probe called a “molecular beacon.” 13 The 
design they proposed was simple: a DNA oligonucleotide, with a “probe sequence” of 15-35 
nucleotides and “stem sequences”, 5-10 nucleotides in length, whose complementary sequences 
enabled the oligonucleotide to anneal in a hairpin structure. The oligonucleotide also contained 
a fluorophore, 5-(2'-aminoethyl) aminonapthalene-1-sulfonic acid (EDANS), attached by a 
hydrocarbon linker to its 5' phosphate group; a quencher molecule, 4-(4'-
dimethylaminophenylazo)benzoic acid (DABCYL), was attached by a similar linker to the 3' 
hydroxy group of the probe.  
 
Figure 5. Tyagi and Kramer’s proposed molecular beacon structure. 
When in the hairpin conformation, the fluorophore and quencher were brought into adequate 
proximity to enable quenching of the EDANS fluorescence by the DABCYL moiety via Förster 
resonance energy transfer (FRET). However, in the presence of DNA containing a sequence 
complementary to the probe sequence, hybridization of the probe to the target would cause the 
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hairpin to unwind, increasing the distance between the fluorophore and quencher. Restoration 
of fluorescence would thus signal the successful binding of the oligonucleotide to its target.  
This new technology offered two major benefits. First, the fact that the molecular beacon was 
“switched off” in its native conformation removed the necessity to wash away unhybridized 
probe. Second, the added feature of the hairpin stem enabled fine-tuning of the probe-target 
hybridization stability so that the probe could be designed to recognize target mismatches as 
minute as a single base pair. As such, molecular beacons could conceivably have applications in 
both real time and in vivo assays. They could also be synthesized with relative ease, using 
established automated DNA synthetic techniques, and purified via column chromatography. 
Since their introduction in 1996, interest in molecular beacons has grown rapidly. Among other 
applications, MBs have been described as probes for single nucleotide polymorphisms (SNPs), 
14 mRNA detection in living cells, 15 and identification of viruses in cells. 16  
1.4 Fluorescence and Quenching 
1.4.1 Fluorescence 
Fluorescence is a form of luminescence in which a molecule absorbs a photon at a particular 
wavelength, passes to an excited state, and emits the photon at a longer wavelength. 17 To 
understand the difference between fluorescence and other forms of energy dissipation, a closer 
examination of processes by which an excited light-absorbing molecule (chromophore) can 
return to the ground state is merited. 
A chromophore at the ground state (S0), on absorbing a photon, will be transformed to an 
excited state (S2). The molecule will then return to the lowest possible excited state (S1) by 
dissipating energy as heat in a phenomenon known as internal conversion (IC). 
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Figure 6. Jablonski diagram showing electronic transitions in the absorption and emission of 
photons by chromophores. 
Once S1 is reached, the molecule can return to the ground state by various modes of energy 
dissipation. Three of the most common are: 
1. The remaining absorbed energy is dissipated as heat in a non-radiative process. 
2. The photon undergoes intersystem crossing (ISC) to an excited triplet state (T1), and the 
energy is emitted as phosphorescence. 
3. The photon returns from S1 to S0 by a radiative process, as fluorescence.  
The longer wavelength at which fluorescence is emitted can be explained by the loss of energy 
as heat during IC. Chromophores that emit energy as fluorescence are known as fluorophores.  
Certain photophysical properties will be constant for fluorophores under a given set of 
conditions, and can be measured. Changes in these properties can signal changes in the 
immediate environment of the fluorophore, and thus fluorescence can be extraordinarily useful 
in bioanalysis. Among the most readily characterized fluorescence properties are absorption and 
emission maxima/Stokes shift; fluorescence quantum yield; and molar extinction coefficient.  
The absorption maximum (λmax) of a fluorophore indicates the wavelength of light at which it 
can most efficiently be excited. The emission maximum indicates the wavelength at which light 
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will be emitted from S1. 17 The difference in these two wavelengths is called the Stokes shift. 
Changes in this shift can be used in such applications as detecting cancerous tissues. 18  
Fluorescence quantum yield (Φ) is a measurement of the efficiency of a fluorescence process. It 
can be quantified as the ratio of the number of photons emitted by a fluorescent compound as 
fluorescence, to the number of photons absorbed by the compound: 
€ 
Φ =
photons emitted
photons absorbed =
kr
kr + ki + kisc  
Where kr, ki, and kisc are the rate constants for fluorescence emission, heat emission, and 
intersystem crossing respectively. 19 Thus a high Φ is often indicative of an efficient, and 
therefore highly fluorescent, fluorophore. 
The molar extinction coefficient, or molar absorptivity (ε), is a measure of how well a given 
chromophore absorbs light at a particular wavelength (usually λmax). It can be related to the 
Beer-Lambert law, A = εcℓ, where A = absorbance, c = concentration, and ℓ = path length 
(usually 1 cm when measured in a cuvette). A fluorophore with high quantum yield and molar 
absorptivity is considered to be “bright”, and its fluorescence is expected to be detectable at 
lower concentrations.20 
1.4.2 Quenching Modes: FRET and Collisional 
Förster resonance energy transfer can be defined as the nonradiative process by which an 
excited donor molecule transfers electronic excitation to a ground state acceptor molecule. 
Theodor Förster first described this phenomenon in 1945. 21 He ascribed the transfer to dipole-
dipole resonance interaction between the donor and acceptor molecules, and also noted the 
distance-dependence of the rate of transfer, which he quantified as 1/r6, where r is the distance 
between two molecules. 10-100 Å is considered the maximum range for FRET to occur, while 
20-70 Å – the “Förster distance” – is the distance at which FRET occurs with 50% efficiency. 
This scale was recognized as ideal for measuring distance relationships between biomolecules.22 
In a molecular beacon, a flurophore functions as the donor and a quencher acts as the acceptor. 
23 Apart from proximity, the major requirement for FRET to occur between the fluorophore and 
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quencher of a molecular beacon is that the emission wavelength of the fluorophore must 
overlap with the absorption wavelength of the quencher. Energy emitted by the fluorophore on 
emission will thus be absorbed by the quencher; on relaxation, the quencher will emit the 
energy as heat, and fluorescence will not be observed. 
 
Figure 7. Wavelength overlap and proximity requirements for FRET. 
Apart from FRET, another quenching mechanism observed in molecular beacon fluorophore-
quencher pairs is collisional quenching, which involves the direct transfer of energy from the 
fluorophore to the quencher during physical contact of the two molecules. 24 This mode of 
quenching has been observed between the universal quencher DABCYL and florophores whose 
emission wavelengths do not overlap adequately to enable FRET. 25  
1.4.3 DABCYL Quenching Mechanism 
Cis-trans photoisomerization around a double bond has been demonstrated as a self-quenching 
mechanism in fluorophores containing such bonds; 26 this same mechanism can easily be 
extended to the diarylazo moiety of DABCYL and its analogs.  
10 
 
 
Scheme 1. Trans-cis isomerization of azobenzene. 
Azobenzene, considered a model molecule for compound bearing the diarylazo moiety, is 
known to exist as an equilibrium between the more stable trans isomer and the cis isomer. 19 
Upon irradiation with UV light, the trans compound undergoes photoisomerization to the cis 
isomer. The return process can be mediated either by light or, in the absence of light, by thermal 
isomerization to the more stable trans form. 
Numerous mechanisms have been proposed for this isomerization process, of which two, 
rotation and inversion, are the most commonly accepted. Rotation involves a breakage of the 
N=N bond to enable rotation between that bond; inversion proceeds by inversion of a nitrogen 
lone pair and rotation around the C-N bond. both are corroborated by experimental evidence, 
and in some cases a mixture of mechanisms has been proposed.19,27 
 
Scheme 2. Proposed mechanisms for azobenzene isomerization. 
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The quenching of fluorescence by DABCYL can thus be attributed to absorption of a photon 
from the fluorophore which then mediates photoisomerization from the trans to cis isomer, 
preventing the photon from being released as fluorescence. 
1.5 Peptide Nucleic Acid (PNA) 
The first molecular beacons consisted of DNA oligonucleotides. DNA molecular beacons are 
still widely used in such applications as real-time PCR assays and Southern blots, largely due to 
their wide commercial availability and ease of synthesis. However, while DNA MBs function 
effectively in vitro, they present problems for in vivo applications (namely, the tendency of 
single-stranded DNA to be degraded by nucleases in cells). 28 Numerous modifications have 
been proposed to the original molecular beacon design; one of the most promising is the use of 
peptide nucleic acid (PNA) peptides instead of DNA oligonucleotides as molecular beacons. 29  
First reported in 1991, PNA is a nucleic acid analog with a backbone of N-(2-aminoethyl)-
glycine units linked by peptide bonds. 30 Purine and pyrimidine bases are linked to the backbone 
by methylene carbonyl bonds. The bases can recognize their complements in DNA and RNA 
via standard Watson-Crick hydrogen bonding; however, the nonstandard backbone is not 
recognized by nucleases, leading to increased stability of PNA in living cells. Also, the 
backbone is neutral, preventing the electrostatic repulsion such as that between negatively 
charged phosphate backbones that can destabilize DNA or RNA duplexes. As such, PNA 
oligomers can form highly stable duplexes and triplexes with complementary nucleic acid 
sequences both in water, and in solutions with low salt content. 31  
 
Figure 8. Structure of peptide nucleic acid (PNA). 
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A further benefit of PNA-based molecular beacons is that they do not require base-pairing stem 
sequences for quenching of fluorescence in the absence of their targets. Rather, intramolecular 
interactions such as base-stacking can cause the oligomer to fold in on itself in solution, 
bringing the quencher and fluorophore into the close proximity required for FRET. 32 This 
quality can potentially simplify the design of PNA-based molecular beacon sequences. 
1.6 Overview 
The research described in this report focuses on the synthesis of FRET-based PNA and DNA 
molecular beacons. Chapter 2 describes a proposed methodology for the synthesis of a PNA 
MB sequentially derivatized with quencher and fluorophore moieties via on-resin copper-
catalyzed azide-alkyne cycloaddition (CuAAC), commonly known as “click chemistry”. Three 
fluorescent molecules have been derivatized with alkyne moieties for incorporation into azide-
containing PNA, and their fluorescence properties characterized. Optimization of the on-resin 
click chemistry and progress toward the synthesis of differentially labeled PNA molecular 
beacons are described. 
Chapter 3 focuses on the synthesis of a pyrrolocytidine phosphoramidite incorporating the 
DABCYL diarylazo moiety. Two potential synthetic routes are explored toward the synthesis of 
a phosphoramidite suitable for incorporating into a DNA molecular beacon. The unprecedented 
addition of a dimethoxytrityl group to the heterocyclic ring system of the pC nucleobase is 
described. 
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Chapter 2 - Toward Multiple Labelling of PNA Oligomers by 
Sequential Azide-Alkyne Cycloaddition Reactions 
2 Chapter Introduction 
While PNA represents a promising framework for molecular beacons, the incorporation of 
fluorophore and quencher moieties into such MBs represents a challenge. The traditional 
approach, in the Hudson research group33 and others, 34 has been to synthesize PNA monomers 
that incorporate these moieties. Such monomers are generally obtained via multi-step syntheses 
that can be time consuming and low yielding. Furthermore, characterization of their 
photophysical properties can sometimes yield disappointing results. A simpler approach to PNA 
MB derivitization, therefore, is desirable. 
One method that has emerged as a possibility for PNA derivatization is the copper-catalyzed 
azide-alkyne cycloaddition, or CuAAC. First described simultaneously by Sharpless and Meldal 
in 2002, 35,36 the CuAAC reaction is a relatively simple, regiospecific reaction that involves the 
covalent linking of a terminal alkyne with an azide group to form a stable triazole moiety.  
 
Scheme 3. General scheme for CuAAC. 
This reaction belongs to the general class of what Sharpless himself described as “click 
chemistry”. 37 In fact, CuAAC is all but synonymous with the term “click chemistry”; as such, 
CuAAC and “click” will be referred to interchangeably in this text. 
Two common approaches are used to perform CuAAC: 1) a copper (II) catalyst is reduced to 
copper (I) in situ by a reducing agent such as ascorbate, 35 or 2) a copper (I) catalyst is 
employed in the presence of base, typically an amine such as diisopropylethylamine (DIPEA). 
38 The reaction is run at room temperature, preferably in solvents such as water, and often 
results in swift conversion of starting materials to the 1,3-cycloaddition product. 
R
N N N + R' Cu(I) (cat) N
N
N
R'
R
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The CuAAC reaction has been previously explored as a method for derivatizing PNA oligomers 
using solid-phase (“on-resin”) reactions. 39,40 Recently, the Hudson group published the 
synthesis of a simple Fmoc-protected PNA monomer containing an azide moiety. 41 This PNA 
monomer can be easily incorporated into PNA peptides by automated or manual solid-phase 
synthesis, enabling the derivatization of oligomers by on-resin CuAAC with compounds 
containing terminal alkynes. 
 
Figure 9. Azide-containing PNA monomer. 
An obvious application of this chemistry is the incorporation of fluorophore and/or quencher 
moieties into PNA molecular beacons. In fact, current work in the Hudson group has included 
the synthesis of a quencher-free molecular beacon in which an alkyne-derivatized pyrene 
moiety is incorporated into PNA by on-resin CuAAC. 
Another advance toward CuAAC-derivatized PNA molecular beacons was achieved in the 
Hudson group with the design and synthesis of an analog of the “universal quencher” 4-(4'-
dimethylaminophenylazo)benzoic acid (DABCYL). 42 This DABCYL analog contains an 
alkyne moiety that can serve as a “click partner” with the azide PNA monomer.  
 
Figure 10. DABCYL analog alkyne I. 
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It remained to establish a library of novel “clickable” fluorophore derivatives that could also be 
incorporated into PNA via on-resin click chemistry. Such fluorophores could conceivably find 
utility beyond incorporation into molecular beacons; one potential application might be the 
labeling of proteins by attaching the fluorophores to noncanonical azide-containing amino acids 
using click chemistry. 43  
Finally, a methodology was devised to enable the incorporation of both a quencher and 
fluorophore moiety into a PNA peptide via on-resin CuAAC. A major application of molecular 
beacons is the detection of single nucleotide polymorphisms (SNPs), owing to the selectivity of 
binding that can be tuned to recognize mismatches of a single base pair. As such, the proposed 
nuclebase sequence was designed to function as a probe for the Trp1282Ter mutation 
(W1282X) of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.44  
2.1 Proposed Synthetic Scheme for Molecular Beacon 
A four-step methodology was devised for the synthesis of a PNA molecular beacon, involving 
two separate rounds of automated peptide synthesis and two separate manual on-resin CuAAC 
reactions.  
Step 1 of the scheme is the synthesis of partial peptide (PNA 1) via standard Fmoc chemistry, 
incorporating the azide PNA monomer toward the C terminus. Step 2 is incorporation of 
quencher via on-resin CuAAC to yield PNA 2. Step 3 involves completion of peptide synthesis 
to yield the complete PNA sequence with a second azide monomer near the N terminus (PNA 
3). Finally, step 4 is incorporation of alkyne-derivatized fluorophore via on-resin CuAAC to 
yield the complete MB (PNA 4). 
This methodology, if successful, would represent a novel and relatively simple method for the 
derivatization of PNA oligonucleotides as molecular beacons. The alkyne-modified quencher 
and fluorophores can be easily synthesized, and can all function as “click partners” with the 
azide PNA monomer, representing a potential improvement over standard syntheses of 
molecular beacons incorporating modified fluorescent/quenching PNA monomers. While all 
three fluorophores synthesized have previously been described, 45-47 two of the compounds – the 
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acridine and acridone derivatives – have not previously been reported for use as CuAAC “click 
partners”.  
 
Scheme 4. Proposed methodology for synthesis of PNA molecular beacon. 
2.2 Quencher and Fluorophores 
2.2.1 DABCYL Alkyne Analog Quencher 
Synthesis and characterization of the DABCYL analog alkyne 1 has previously been achieved 
in the Hudson group. 42 Following the synthesis of an iodinated precursor, the terminal alkyne 
can be readily installed via Sonogashira coupling with TMS acetylene in excellent yields of up 
to 97%. TMS deprotection then affords the free DABCYL alkyne in quantitative yield. 
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2.2.2 Fluorophore I: Acridine 
2.2.2.1 Rationale 
The first fluorophore targeted for alkyne derivatization was acridine. This polycyclic aromatic 
compound is a well-characterized fluorophore48 that has also previously been reported as a 
DNA intercalating agent. 49 A common derivative of acridine, 9-aminoacridine, is intensely 
fluorescent with a reported quantum yield of 0.99 in ethanol. 50  
 
Figure 11. Acridine (left) and 9-aminoacridine. 
It was expected that a 9-aminoacridine derivative alkylated at N9 with a propargyl group would 
thus be both highly fluorescent and easily incorporated into azide-containing PNA via on-resin 
CuAAC. 
 
Figure 12. 9-propargyl aminoacridine derivative II. 
2.2.2.2 Synthesis 
A preparation method for alkylated 9-aminoacridines had previously been reported by Reisch 
and Gunaherath, 45 and this method was employed for initial attempts at synthesizing compound 
2. 9-Chloroacridine (initially purchased from Sigma-Aldrich, later synthesized according to a 
literature procedure51) was fused with phenol at 110º C, and propargylamine HCl salt was 
added along with DIPEA to deprotonate the propargylamine salt in situ.  
N N
NH2
N
NH
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Scheme 5. Initial scheme for synthesis of compound II. 
This method resulted in a mixture of products that was difficult to purify. Subsequent attempts 
to perform the reaction without added base enabled the isolation of a small amount of yellow 
solid which appeared to correspond to reported values for compound II by 1H NMR. However, 
this solid was acquired in low yield and also resisted purification.  
Fresh propargylamine was purchased and the reaction was reattempted according to Reisch and 
Gunaherath’s conditions. In this instance the starting material was consumed quickly, but the 
product obtained was a bright yellow powder, highly fluorescent in solution, whose RF by TLC 
and 1H NMR spectrum did not conform to known values for the desired product. Initially it was 
believed that this compound might be acridone, a well-known byproduct of the hydrolysis of 9-
chloroacridine; 45 however, the 1H NMR spectrum, RF by TLC, and fluorescence of acridone 
did not correspond to this byproduct. Comparison of the 1H spectrum of 9-aminoacridine52 to 
that of the byproduct indicated that said byproduct was in fact 9-aminoacridine rather than 
acridone.  
Given the unsatisfactory results obtained from Reisch and Gunaherath’s synthetic method, a 
gentler approach was attempted by stirring 9-chloroacridine with propargylamine in 
acetonitrile.  
 
Scheme 6. Revised procedure for synthesis of HCl salt of compound II. 
N
NH
Phenol, DIPEA
N
Cl
NH3++
Cl-
II
N
H+
NH
MeCN, 50º, 24 hrs
N
Cl
NH2+
Cl-
70%
19 
 
The reaction was sluggish at room temperature, but on heating the mixture to 50ºC rapid 
formation of a yellow precipitate was observed. This solid was isolated via filtration and 
appeared by 1H NMR to be the hydrochloride salt of the desired acridine alkyne derivative. 
Yield of the product obtained was 70%. Thus this synthetic method represents an improvement 
on Reisch and Gunaherath’s procedure in yield, mildness of conditions, and ease of purification 
of the product. 
The 9-aminoacridine alkyne was subjected to a CuAAC reaction with benzyl azide to verify its 
suitability as a CuAAC “click partner”. No reaction was observed when the click reaction was 
attempted with compound 1 using standard ascorbate/copper sulfate click conditions, 53 so it 
was decided to reattempt the click reaction using a procedure originally developed using acetic 
acid, CuI and DIPEA in DCM. 54 Because the acridine alkyne was itself an HCl salt, the acetic 
acid was omitted from the reaction conditions. This method proved successful, with starting 
material consumed in 0.5 hours as determined by TLC, and formation of the triazole “click 
product” confirmed by 1H NMR. 
2.2.3 Fluorophore 2: 4-Nitrobenzo-2-oxa-1,3-diazole (NBD) 
2.2.3.1 Rationale 
The second fluorophore targeted for alkyne derivatization was 4-nitrobenzo-2-oxa-1,3-diazole 
(NBD).  
 
Figure 13. Structures of NBD-Cl and alkyne derived from NBD (compound III). 
The intense fluorescence of benzofurazan compounds with amine moieties at the 7 position was 
first reported in 1968. 55 The ready reaction of the non-fluorescent 7-chloro derivative of NBD 
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with amines suggested applications in the fluorescent tagging of biological molecules such as 
amino acids. 56  
The NBD fluorophore has a reported emission maximum at 535 nm in EtOH46 and may not be 
ideal as a FRET partner for a DABCYL analog. However, it has the interesting property of 
being highly environmentally sensitive. Notably, the intensity of its fluorescence is extremely 
solvent-dependent, with markedly higher fluorescence noted in organic solvents relative to 
polar solvents such as water; furthermore, a red shift in emission is noted with increasing 
polarity of solvent. 56 These qualities have led to extensive deployment of NBD fluorophores as 
tags for lipids and cholesterols.57 
Recently, the NBD fluorophore was also shown to have potential application as a DNA 
mismatch probe, when Thiagarajan et al. reported a probe system with NBD ligands capable of 
inserting themselves into a probe DNA strand containing an abasic site. 58 The covalent 
incorporation of an NBD moiety into a molecular probe might enable identification of abasic 
sites in nucleic acid targets. 
2.2.3.2 Synthesis  
Synthesis of the alkyne-derivatized NBD compound was achieved with much greater ease than 
that of the acridine derivative, using an established literature procedure. 46 NBD-Cl, a 
commercially available compound, was stirred with propargylamine in acetonitrile at room 
temperature, and the product was isolated in good yield via column chromatography. 
 
Scheme 7. Synthesis of compound III. 
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A “test click” was performed with this compound and benzyl azide according to conditions 
already employed by Key and Cairo. 46 The triazole product was isolated and its structure 
confirmed by 1H NMR, although the reaction also produced an insoluble dark solid. 
2.2.4 Fluorophore 3: Acridone 
2.2.4.1 Rationale 
Acridone is a well-studied fluorophore with strong fluorescence emission in the 400-450 nm 
range. Like acridine, it has therapeutic applications as a DNA intercalator, 59 and has also been 
reported as a base-discriminating fluorophore for the detection of SNPs. 60 Acridone has been 
reported as forming a FRET pair with DABCYL. 61  
 
Figure 14. Acridone. 
This compound was not originally targeted for alkyne derivitization. However, when the 
byproduct from attempts to synthesize compound II was believed to be acridone, the intense 
fluorescence of the byproduct prompted investigation into acridone and its properties. Apart 
from its potential for FRET pairing with DABCYL, acridone also has the interesting property 
of being quenched by guanine.61This suggests the possibility of employing this fluorophore in a 
quencher-free PNA molecular beacon. 
 
Figure 15. N-propargyl acridone derivative IV. 
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2.2.4.2 Synthesis 
The starting material, acridone, was readily synthesized according to a literature procedure. 62 
The alkynyl derivative was obtained by deprotonation of the amine with sodium hydride and 
alkylation with propargyl bromide.  
 
Scheme 6. Scheme for synthesis of compound IV.47 
Initial “test click” reactions with compound IV with previously used conditions53resulted in no 
product formation, possibly due to the lack of solubility of the acridone alkyne in polar 
solvents. The acridone alkyne was successfully “clicked” to benzyl azide with CuI using 
acetonitrile as solvent/ligand, 63 although a reaction time of two days was required for full 
consumption of starting material as determined by thin layer chromatography.  
2.3 Fluorescence Studies – Fluorophores 
Absorption/emission spectra, quantum yields, and molar extinction coefficients were obtained 
for compounds II, III, and IV in ethanol. 
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Figure 16. Absorption/emission spectra for compounds II, III, and IV in ethanol. 
Table 1. Fluorescence data for fluorophores acquired in ethanol. 
Alkyne λ  max 
(absorbance) 
λ  max 
(emission) 
Quantum 
yield 
Molar 
absorptivity  
(L•M-1•cm-1) 
9-aminoacridine (II) 400 490 0.09 8800 (411 nm) 
NBD (III) 450 515 0.41 17379 (449 nm) 
Acridone (IV) 395 410 0.76 10703 (396 nm) 
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The quantum yield of 0.09 for compound II was disappointing, especially relative to that of 9-
aminoacridine. However, 9-aminoacridine has in fact been shown to undergo a marked decrease 
in fluorescence upon alkylation of the exocyclic amine group, 64,65 possibly due to steric 
clashing of the bulky alkyl group disrupting planarity of the ring system. 66 Compound III had a 
respectable quantum yield of 0.41, although this is lower than the reported literature value of 
0.57. Of the three fluorophores, compound IV had the highest quantum yield at 0.76, 
comparable to literature values for acridone at 0.78.67 
2.4 Early Attempts Toward Molecular Beacon Synthesis 
2.4.1 First Attempt 
Synthesis of the initial 9-mer containing an azide residue near the C-terminus (PNA 1) was 
achieved on a 5 µmol scale via standard Fmoc chemistry using NovaSyn TGR rink amide resin 
with a substitution of 0.045 meq/g. A 3 mg portion of resin was cleaved using 
TFA/triethylsilane and the cleaved peptide was examined by liquid chromatography mass 
spectrometry (LC-MS). The concurrent LC trace of the cleaved peptide indicated that it was of 
sufficient purity to carry forward to the next step.  
The first on-resin click reaction, using compound I as a “click partner” with the azide 
monomer, was attempted using conditions that had been previously been successful for on-resin 
click chemistry with this monomer. 41  
After overnight reaction, a portion of the resin was again cleaved and checked by mass 
spectrometry – the LC trace indicated that the reaction was roughly 50% complete. Additional 
reagents were added and the reaction was continued. After 48 more hours of reaction the 
starting material was no longer visible in a sample of cleaved resin by LC-MS; however, the LC 
trace was increasingly “messy”, with other byproducts appearing to have formed. However, 
given that no starting material appeared to remain, this quencher-derivatized resin was carried 
forward to the next step. Automated synthesis of the full 18-mer (PNA 3) was attempted under 
the previously described conditions. However, on completion of the automated synthetic run, a 
sample of cleaved peptide was examined by LC-MS and it was determined that no discernible 
PNA 3 had formed. In fact the LC-MS spectra were nearly identical to those of the starting 
peptide, with the Fmoc groups on the peptide apparently still intact.  
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It was theorized that the long reaction time and numerous equivalents of reagents required to 
force the click reaction to completion might have resulted in chemical or mechanical 
degradation of the resin which rendered the second round of automated peptide synthesis 
unfeasible. Therefore, it was decided to explore alternative conditions for the on-resin CuAAC.  
For testing purposes 500 mg of TGR-R resin was loaded with azide PNA monomer. The first 
alternative on-resin click procedure attempted was one developed by Jagasia et al. 68 for the 
cyclization of peptides containing alkyne and azide residues via on-resin CuAAC. The 
procedure used DMSO and MeCN as the solvent mixture. The intended purpose of the DMSO 
was to swell the resin, but this solvent also aids in dissolving the alkyne, which is a further 
advantage as solubility had previously been an issue with test click reactions involving 
compound IV. Furthermore, MeCN can also function as a ligand in CuAAC, which may also 
aid the reaction. 35 Finally, 2,6-lutidine was used as the base; lutidine is considerably less basic 
than DIPEA, with a pKa of 6.65, 69 so the use of this base might also prevent the Fmoc group on 
the terminal residue from being removed by the amine base used for Cu(I)-mediated CuAAC.  
A “test click” was performed using this procedure to couple compound 4 to the resin-bound 
azide monomer. The literature procedure was deviated from only in that a twofold molar excess 
of fluorophore was used (the original procedure was developed for 1:1 azide/alkyne 
equivalents). After overnight reaction the reaction appeared complete as verified by LC-MS. A 
second test reaction was performed, this time with a shorter reaction time of 4 hours; once 
again, the reaction appeared successful. Successful on-resin “test clicks” were performed using 
compounds I, II, and III. It is interesting to note that although the “test click” of the NBD 
fluorophore with benzyl azide had produced an insoluble byproduct, the on-resin test click 
proceeded cleanly with no byproduct observed. This procedure appears promising for the on-
resin CuAAC steps involved in the four-step molecular beacon synthetic methodology. 
2.4.2 Molecular Beacon Synthesis – Second Attempt 
For the second attempt at molecular beacon synthesis, a shorter sequence (PNA 1a) was 
synthesized using using cross-linked ethoxylate acrylate (CLEAR)-amide resin preloaded with 
lysine to a substitution of 0.094 meq/g. While this substitution is considered high for PNA 
synthesis, CLEAR resin is designed for difficult peptide syntheses; it therefore was expected 
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that PNA synthesis would proceed without problems. In fact this seemed to be the case, with 
successful synthesis of PNA 6-mer verified by LC-MS. 
 
Figure 17. PNA 6-mer 1a. 
The DABCYL analog quencher alkyne was then installed on the peptide using Jagasia et al.’s 
conditions for on-resin CuAAC, again with a 2x molar excess of alkyne. After overnight 
reaction a portion of the resin was cleaved and the peptide was examined by LC-MS. The 
spectra confirmed the disappearance of the starting material and indicated a clean peak 
corresponding to the clicked product. 
The resin containing the clicked peptide was returned to the automated synthesizer and the 
synthesis was continued. However, a sample of cleaved peptide examined by MS appeared to 
contain only acylated (“capped”) PNA, indicating that the second attempt at extending the 
peptide on the ABI automated synthesizer was thus also unsuccessful. 
 
Figure 18. Comparison of LC traces at 260 nm for clicked PNA 1a (top) with clicked  
PNA 1. 
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2.5 Revised Synthetic Scheme 
Following the failure of two separate attempts to extend “clicked” resin on the ABI synthesizer, 
it was proposed that this was not an ideal method for completing synthesis of the full peptide. 
Therefore, a revised synthetic scheme was devised. 
This procedure begins with automated synthesis of PNA 1b, including the entire target 
sequence, up to the second azide monomer. This longer peptide would undergo the first round 
of on-resin CuAAC; the second azide monomer and the second lysine residue would then be 
installed by manual solid phase peptide coupling, and the second on-resin “click” reaction could 
then be performed to yield PNA 4. While slightly more complex than the initial scheme, this 
methodology would have the benefit of allowing troubleshooting when coupling the final 
residues to the first clicked peptide. 
 
Scheme 8. Revised scheme for molecular beacon synthesis. 
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2.6 Toward Synthesis of Molecular Beacon by Revised Scheme 
2.6.1 First Attempt 
The first attempt at synthesis of PNA 1b was performed on the ABI synthesizer as previously 
described, again using CLEAR resin preloaded with lysine to a substitution of 0.094 meq/g. 
Following synthesis, the cleaved peptide was again examined using LC-MS. While the full 
peptide was identifiable, the spectra also indicated the presence of an acylated peptide only six 
residues long. Both product masses were found under a single peak both in the MS 
chromatograph and the LC trace, which made it difficult to determine the ratio of full peptide to 
6-mer. In the hope of assessing the relative amount of 16-mer compared to the 6-mer 
byproduct, a portion of resin was cleaved and run on a polyacrylamide gel according to a 
procedure previously developed in the Hudson group. 70  
 
Figure 19. Separation of PNA by gel electrophoresis. Lane 1 contains a PNA sequence 14 
monomers in length, used as a standard; lane 2 contains PNA from attempted synthesis of PNA 
2A. (Smear below band is indicative of unpurified PNA.) 
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This gel showed two bands, of similar intensity, that had run a very similar distance through the 
gel. The closeness of the two bands, despite the disparity in molecular weight between the two 
identified PNA sequences, may be explained by the similar charge-mass ratios of the two 
sequences in acidic buffer.70 
An on-resin CuAAC reaction was performed with DABCYL analog alkyne I in the hope that 
the clicked peptides would separate out more readily and their relative amounts would be 
discernable via LC-MS. However, as with the unclicked peptide, the clicked peptides were both 
found under the same peak in both the chromatograph and LC trace. A second gel was run 
using the clicked peptide, with a near identical result (data not shown). 
Excision of the two major bands from the gel and extraction of the PNA yielded very poorly 
concentrated samples – in fact, only the 6mer could be discerned by LC-MS. It seemed 
apparent that the 6-mer was a major product of the synthesis, possibly due to aggregation of the 
PNA on the highly substituted resin. It is interesting to note that the 6-mer corresponds in 
length to the acylated product obtained from the attempt to extend the clicked PNA 6-mer on 
the peptide synthesizer. This suggests that the failure of the second round of automated 
synthesis may not be due to degradation of the resin or impurities from the click reaction, but 
may have also been caused by aggregation of the PNA on the resin. 
2.6.2 Second Attempt: Poly-T Sequence 
Given the difficulties attendant on synthesizing the CFTR probe sequence, it was decided to 
attempt the molecular beacon synthesis using a simpler “model” sequence consisting largely of 
thymine PNA monomers: 
 
Figure 20. Sequence of poly-thymine model PNA sequence 1c. 
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Automated synthesis of the poly-T sequence proceeded as previously described. However, 
MS/UPLC analysis of the synthesized peptide once again showed that while the full peptide 
could be identified, the major product appeared to be a truncated sequence – in this case, a 7-
mer. A second attempt at automated synthesis of PNA 1c, this time with extremely careful 
drying and handling of all PNA monomers and reagents, yielded a near-identical result. 
In order to eliminate the possibility that the synthetic difficulties were caused by 
malfunctioning of the ABI synthesizer, a fully manual solid-phase synthesis of the poly-T 
sequence was attempted, again on a 5 µmol scale using the CLEAR resin substituted to 0.094 
meq/gram. Coupling efficiency was monitored by Kaiser test. 71 Initially, the synthesis appeared 
to be proceeding well, but after the sequence had grown to seven monomers, the Kaiser test 
indicated an inefficient coupling. It appeared that the manual synthesis was failing at the same 
point as the automated synthesis, possibly due to aggregation on the resin. Two further attempts 
to couple more T monomer to the resin, using DMSO as a solvent as recommended to disrupt 
aggregation, 72 did not visibly reduce the amount of free amine discernible by Kaiser test. A 
portion of resin was cleaved and the peptide examined by LC-MS. A prominent peak could be 
detected for the desired 8-mer, but peaks for both Fmoc-protected and Fmoc-unprotected 7mer 
were also found. The failure of the resin deprotection step, normally achieved quite readily by 
shaking the resin with 20% piperidine in DMF, is further indicative of aggregation of the poly-
T peptides on the resin. 73 At this point, time constraints necessitated a halt in the work. 
2.7 Conclusion and Outlook 
A synthetic scheme was devised for the synthesis of a PNA molecular beacon differentially 
labeled with a flurophore and quencher by on-resin CuAAC. A library of three simple alkyne-
derivatized fluorescent molecules was synthesized, their fluorescence properties were 
characterized, and their viabilities as on-resin “click partners” with an azide PNA monomer 
were demonstrated via a clean, fast, and efficient on-resin click procedure. It is unfortunate that 
technical difficulties impeded progress of the full synthesis of the molecular beacon. However, 
immediate future work will involve investigation into resins more suitable for PNA peptide 
synthesis, as it seems apparent that many synthetic difficulties can be attributed to aggregation 
of PNA on the resin used despite claims that said resin is useful for the synthesis of difficult 
31 
 
sequences. This will likely enable successful synthesis of PNA 1a, or a simpler test sequence, 
and exploration of the synthetic methodology can then continue. 
2.8 Experimental 
General Remarks 
All chemicals were obtained from commercial sources and used without further purification 
except where noted. NMR spectra were acquired on a Varian Mercury 400 instrument. 
Chemical shifts are reported in parts per million (δ), were measured from tetramethylsilane (0 
ppm), and are referenced to the residual proton in the deuterated solvent: acetone – d6 (2.05 
ppm), CDCl3 (7.26 ppm), DMSO – d6 (2.49 ppm) for 1H NMR and CDCl3 (77.0 ppm) and 
DMSO – d6 (39.5 ppm) for 13C NMR spectroscopy. Multiplicities are described as s (singlet), d 
(doublet), t (triplet), q (quartet), m (multiplet), and br s (broad singlet). Coupling constants (J) 
are reported in hertz (Hz). High resolution mass spectra (HRMS) and low resolution mass 
spectra were obtained using electron impact (EI) or electrospray ionization (ESI) methods. 
Preparation of 9-chloroacridine:51 
N-phenylanthranilic acid (10.0 g, 47 mmol) was placed in an RBF and POCl3 (50.0 g, 326 
mmol) was added via slow pour. The mixture was placed in an oil bath and slowly heated to 
90ºC. The mixture was cooled to room temperature, then reheated to 135º and refluxed for two 
hours. Excess POCl3 was removed by vacuum distillation and the dark brown mixture was 
cooled to room temperature. Concentrated aqueous ammonia (50 ml), chloroform (50 ml), and 
ice were combined in a beaker and poured into the flask containing the crude product. The 
mixture was stirred until it became cloudy and orange-brown. The mixture was partitioned in a 
separatory funnel and the organic layer was collected. The aqueous layer was washed with 
chloroform (3 x 25 ml) and the organic extracts were dried with Na2SO4. Solvent was removed 
to yield the product as a light brown solid that was used without further purification (7.5 g, 
75%). 1H NMR (DMSO-d6) δ: 8.42 (d, J = 8.6 Hz, 2H) 8.22 (d, J = 9.0 Hz, 2H) 7.95 (m, 2H) 
7.80 (m, 2H). – characterization conformed to reported values. 
Preparation of 9-propargylaminoacridine • HCl (compound II): 
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9-chloroacridine (0.500 g, 2.3 mmol) was dissolved in anhydrous acetonitrile. Propargylamine 
(0.258 g, 4.6 mmol) was added and the mixture was heated to 50ºC, then stirred for 24h. The 
bright yellow precipitate was collected via filtration to yield compound II as an HCl salt (0.441 
g, 70%). 1H NMR (DMSO-d6) δ: 10.42 (bs, 1H) 8.74 (d, J = 8.7 Hz, 2H), 8.02 (m, 4H) 7.62 (m, 
2H) 4.88 (s, 2H) 3.68 (s, 1H). HRMS (EI) calcd. for C16H12N2:  232.1000. Found: 232.0991. 
“Test click” of compound II with benzyl azide:54 
DCM (5 ml) and DIPEA (0.0232 g, 0.18 mmol) were combined in an RBF and CuI (0.0069 g, 
0.036 mmol) , compound II (0.050 g, 0.18 mmol), and benzyl azide (0.0273 g, 0.2 mmol) were 
added to the flask. The mixture was stirred for 0.5 hours, then filtered and the filtrate was 
concentrated under vacuum. The resulting orange-yellow solid was precipitated in toluene and 
collected by filtration (0.0454 g, 66%). 1H NMR (DMSO-d6) δ: 8.60 (d, J = 8.6 Hz, 2H) 8.31 
(S, 2H) 7.97 (M, 2H) 7.87 (d, J = 8.6 Hz, 2H) 7.51 (t, J = 7.20 Hz x2, 2H) 7.35 (M, 2H) 7.24 (d, 
J = 8.2, 2H) 5.61 (s, 2H) 5.34 (s, 2H). 
Preparation of 4-propargylamine NBD (compound III):46 
NBD-Cl (0.200 g, 1.0 mmol) was dissolved in dry acetonitrile. Propargylamine (0.138 g, 2.5 
mmol) was added and the dark green mixture was stirred at RT for 1.5 hours. Solvent was 
removed via vacuum and the black crude solid was purified via FCC on silica gel (3:1.5 
hexanes/EtOAc) to yield compound III (0.178 g, 81%). 1H NMR (CDCl3) δ: 8.54 (d, J = 8.5 
Hz, 1H), 6.36 (s, 1H)  6.34 (s, 1H) 4.31 (m, 2H) 2.43 (s, 1H) – characterization conformed to 
reported values. 
“Test click” of compound III with benzyl azide:46 
CuSO4 (0.003 g, 0.018 mmol), sodium ascorbate (0.005 g, 0.018 mmol), and compound III 
(0.020 g, 0.09 mmol) were dissolved in a 1:1 mixture of MeOH:H2O (5 ml). Benzyl azide was 
added dropwise and the mixture was stirred at RT for six hours. Solvent was removed and the 
crude solid was partitioned in CHCl3/H2O and the organic phase was washed with H2O. The 
organic phase was collected and dried with Na2SO4 and solvent was removed to yield the 
product as a yellow-orange solid (0.0093 g, 29%). 1H NMR ((CD3)2CO) δ: 8.53 (d, J = 9 Hz, 
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2H), 8.09 (s, 2H), 7.34 (d, J = 3.1, 8H), 6.62 (d, J = 9, 2H), 5.62 (s, 4H) 4.93, br s, 4H), 3.31 (d,  
J = 5.5, 1H), 2.84 (s, 9H), 2.81 (s, 3H). 
Preparation of acridone:51 
N-phenylanthranilic acid (2.0 g, 9.4 mmol) was placed in an RBF and concentrated aqueous 
H2SO4 (5 ml) was added dropwise. The mixture was stirred until all solids dissolved and the 
red-brown solution was heated to 100ºC in an oil bath and stirred for 4 hours. The solution was 
poured slowly into boiling water, and this mixture was carefully boiled for five minutes. The 
mixture was removed from heat and a pale yellow solid was collected by filtration. The solid 
was transferred to a flask containing boiling aqueous K2CO3 solution. This mixture was 
carefully boiled for five minutes and a yellow solid was collected by filtration and washed with 
H2O. The yellow solid was coevaporated with toluene to yield the product (1.2 g, 66%). 1H 
NMR (DMSO-d6) δ: 11.75 (s, 1H) 8.23 (dd, J = 8.2 Hz, 1.6 Hz, 2H) 7.73 (m, 2H) 7.54 (d, J = 
8.6, 2H) 7.26 (m, 2H). – characterization conformed to reported values. 
Preparation of 10-propargylacridone (compound IV):47 
Acridone (0.500 g, 2.6 mmol) was suspended in 15 ml anhydrous DMF. Sodium hydride (60% 
suspension in mineral oil, 0.112 g, 2.8 mmol) was added in portions and the mixture was heated 
to 50ºC and stirred for 0.5 hours. The yellow-green fluorescent solution was cooled to RT and 
propargyl bromide (0.389 g, 3.1 mmol) was added. The mixture was stirred for 4 h and poured 
into 40 ml H2O. The precipitate was collected via filtration and recrystallized from anhydrous 
EtOH to yield compound IV as pale yellow crystals (0.368 g, 61%). 1H NMR (DMSO-d6) δ: 
8.35 (m, 2H) 7.88 (m, 2H) 7.38 (m, 2H) 5.37 (d, 2H, J = 2.4 Hz) 3.43 (t, J = 2.4 Hz, 1H). 13C 
NMR (CDCl3) δ: 141.62, 134.05, 127.83, 122.64, 121.75, 114.51, 73.84, 36.79. 
“Test click” of compound IV with benzyl azide:63 
MeCN (5 ml) was placed in an RBF and benzyl azide (0.0120 g, 0.09 mmol) was added. 
Compound IV (0.020 g, 0.09 mmol) and CuI (0.0017 g, 0.009 mmol) were added. The mixture 
was stirred at RT for 48 hours; solvent was then removed and a light yellow powder was 
collected by filtration after being washed with H2O (0.0123 g, 37%). 1H NMR (DMSO-d6) δ: 
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8.35 (d, J = 6.6 Hz, 2H) 8.21 (s, 1H) 7.95 (d, J = 8.6 Hz, 2H) 7.82 (m, 2H) 7.32 (m, 8H) 5.81 (s 
2H) 5.53 (m, 2H). 
General procedure for “test click” reactions of alkynes with resin-bound PNA azide 
monomer:68 
A mixture of DMSO (1 ml) and acetonitrile (4 ml) was degassed by bubbling with N2 gas for 5 
min, after which CuI (0.005 g, 2.5 µmol) was added. TGR-R resin downloaded with azide PNA 
monomer (0.050 g, 0.01 mmol) was placed in a manual peptide synthesis vessel, followed by 
alkyne (0.02 mmol). CuI solution (2 ml) and 5 µl 2,6-lutidine were added to the vessel and the 
mixture was degassed by bubbling with N2 gas for 3 minutes. The vessel was flushed with N2, 
sealed, and shaken overnight. The resin was then washed 4x with DCM/DMF. 
 
Synthesis of PNA 8-mer 1: 
The PNA 8-mer containing azide monomer was synthesized on a 5-µmol scale on an Applied 
Biosystems 433A peptide synthesizer. Resin used was NovaSyn TGR (rink amide) resin 
preloaded with Boc-lysine (substitution 0.045 meq/g).  
Synthesis of PNA 2 (incorporation of  DABCYL analog quencher I into PNA 8-mer 1 via 
on-resin CuAAC): 
Resin containing PNA 1 (0.073 g, 3 µmol) was placed in a manual peptide synthesis vessel with 
DABCYL analog I (0.008 g, 30 µmol). DIPEA (0.058 g, 300 µmol), THF (2.5 ml), and 
pyridine (1.5 ml) were added to the vessel, followed by CuI (0.057 g, 300 µmol). The vessel 
was wrapped in aluminum foil and shaken for 3 days, with addition of 30 µmol of compound I 
and 300 µmol CuI each day. The resin was then washed with anhydrous DCM and anhydrous 
DMF (3 cycles). 
Synthesis of PNA 6-mer 1a: 
PNA 6-mer 1a was synthesized as previously described. Resin used was CLEAR-amide resin 
preloaded with Boc-lysine (substitution 0.094 meq/g).  
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Synthesis of PNA 2a (incorporation of  DABCYL analog quencher I into PNA 6-mer 1a 
via on-resin CuAAC): 
A mixture of DMSO (1 ml) and acetonitrile (4 ml) was degassed by bubbling with N2 gas for 5 
min and CuI (0.005 g, 2.5 µmol) was added. Resin containing PNA 6-mer 1a was placed in a 
manual peptide synthesis vessel, followed by compound I (0.0023 g, 0.01 mmol). 2 ml of the 
CuI solution and 5 µmol 2,6-lutidine were added to the vessel and the mixture was degassed by 
bubbling with N2 gas for 3 minutes. The vessel was flushed with N2, sealed, and shaken 
overnight.  
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Chapter 3 – Toward Synthesis of DABCYL Analog 
Pyrrolocytidine Phosphoramidite 
3 Chapter Introduction 
The universal quencher DABCYL has had a long and robust history as a quencher in FRET 
pairs, notably in molecular beacons. The Hudson group had previously entered the realm of 
quenching nucleic acid analogues with the synthesis and evaluation of a PNA monomer 
containing the DABCYL diarylazo moiety.33,74 
 
Figure 21 PNA monomer containing azobenzene moiety in place of a standard nucleobase.  
The design and successful synthesis of the DABCYL alkyne analog 1, previously described in 
this report as a “clickable” quencher for labeling of azide-containing PNA, suggested an 
application in the Sonogashira-cyclization methodology previously employed in the Hudson 
group for the synthesis of fluorescent pyrrolocytidine (pC) base analogs. 75,76  
Incorporating the DABCYL diarylazo moiety into a cytidine analog would result in a custom 
nucleotide capable of quenching fluorescence via FRET while retaining the Watson-Crick face 
required for successful base pairing with guanine.  
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Figure 22. Pyrrolocytidine-based nucleoside V incorporating DABCYL analog alkyne I. 
The free nucleoside had previously been synthesized in sufficient quantity for characterization 
of structure and photophysical properties. 42 In fact, the azo pC nucleoside was shown to have 
molar extinction coefficients in ethanol at 260 and 445 nm superior to those of DABCYL. It 
was thus desirable to synthesize this compound in greater quantities and to complete its 
chemical transformation to a phosphoramidite suitable for incorporation into DNA 
oligonucleotides.  
3.1 Phosphoramidite Chemistry 
Developed in the early 1980s, 77 the phosphoramidite method is a popular method for the solid-
phase synthesis of custom DNA oligonucleotides. Synthesis proceeds in the 3'-to-5' direction by 
sequential coupling of phosphoramidite nucleobases to a solid support, often pre-derivatized 
with a DMT-protected nucleobase. Each coupling follows a 4-step process: 
1. Removal of the DMT protecting group from the 5'-OH using acid, commonly 3-5% 
trichloroacetic acid (TCA) w/v in DCM.  
2. Coupling of the resin-tethered nucleobase to the incoming phosphoramidite using an 
activator such as tetrazole. 
3. Capping of any unreacted sites on the resin using an acetylating agent, commonly acetic 
anhydride. 
4. Oxidation of the P(III) phosphite triester linkage to the more stable P(IV) 
phosphotriester using I2 in H2O. 
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Scheme 9. Phosphoramidite synthesis cycle. 78  
When synthesis is complete, the oligonucleotide is cleaved from the resin using concentrated 
aqueous ammonia. This step also results in the removal of protecting groups such as benzoyl on 
the exocyclic amine groups of C and A, and the β-cyanoethyl group from the phosphate.  
I2/H2O 
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In order to be incorporated into oligonucleotides by phosphoramidite chemistry, DNA 
nucleotides must undergo two modifications: the 5'-OH must be protected by a DMT group, 
and the phosphoramidite group must be introduced at the 3'-OH.  
3.2 Methodologies for Pyrrolocytidine Synthesis 
Two synthetic methodologies have previously been deployed in the Hudson group for the 
synthesis of pC phosphoramidites. The major difference between the two routes lies with the 
iodinated nucleobases used as starting material: 5-iodouridine and 5-iodocytidine. 
 
Scheme 10. Cytidine and uridine routes for synthesis of pyrrolocytidines. 
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The uridine route requires a conversion of the furanouridine ring to pyrrolocytidine by an 
aminolysis reaction with liquid NH3. This atom conversion is necessary due to the fact that the 
furanouracil moiety does not retain the W-C base pairing capabilities of cytosine with guanine. 
In fact, because N3 is deprotonated during ring formation, the furanouracil moiety loses its 
capability to form two hydrogen bonds with adenine, the natural W-C base pairing partner of 
uracil.  
 
Figure 23. Hydrogen bonding capabilities of a) furanouracil-guanine, b) furanouracil-adenine, 
and c) pyrrolocytosine-guanine base pairs. R = H or alkyl substituent. 
Despite the necessity for the aminolysis, the uridine route has several major benefits relative to 
the cytidine route. First, uridine is less costly than cytidine. Also, prior to Sonogashira coupling 
the exocyclic amine of cytidine must be benzoyl protected. In order to ensure selective benzoyl 
protection of the amine, the hydroxyl groups on the ribose sugar ring must first be protected 
with acyl or silyl ether protecting groups. Uridine contains no exocyclic functional groups that 
require protection, bypassing the need for both rounds of protecting group chemistry.  
3.3 Toward Synthesis of DABCYL pC Phosphoramidite – 
Uridine Route 
Synthesis of free nucleoside V had previously been achieved using cytidine as the starting 
point. However, it was decided to attempt synthesis of the phosphoramidite following the 
uridine route, which had been previously used successfully in the group to synthesize 6-
phenylpyrrolocytidine.75 
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Scheme 11. Scheme for synthesis of DABCYL pC phosphoramidite V-4 by uridine route. 
DMT protection of 5-iodocytidine proceeded according to conditions previously described. 75 
The next step in the synthesis was Sonogashira coupling of the DABCYL analog alkyne I to 5-
iodocytidine, followed by cyclization. Previously in the Hudson group, such couplings had been 
accomplished by a one-pot, two-step methodology. However, while the Sonogashira coupling 
proceeded readily, with disappearance of the starting material by TLC after overnight reaction 
at room temperature, attempts at performing the cyclization via addition of base/additional CuI 
and heating the mixture resulted in a “messy” mix of products as determined by TLC. It was 
decided, thus, to reattempt the Sonogashira coupling and isolate/purify the coupled alkyne 
product before attempting cyclization. 
O
OH
HO N
NH
O
O
I
O
OH
O N
NH
O
O
I
O
OH
O N
N
O
NH
NN
N
O
O
O N
N
O
NH
NN
N
P O C
N
N
DMT-Cl, TEA,
Anh. Py
RT, 16 h
1) Pd(PPH3), CuI,
TEA, DMF
RT, 16 h
2) CuI, TEA, MeOH
50ºC, 72 h
V-1
NH3, MeOH
50ºC, 16 h
DCM, DIPEA
RT, 3 hrs
DMT DMT
DMT
P O C
N
N
Cl
DMT
V-3
V-4
O
O
= DMT
O
OH
O N
N
O
O
NN
N
V-2
N
N N
42 
 
 
Scheme 12. Revised scheme for cyclization to furanouridine V-2. 
The second Sonogashira coupling proceeded as before, and a bright orange solid was isolated 
following workup. However, while previous work in the Hudson group had indicated that 
furano ring formation would proceed rapidly under these conditions, the cyclization of the 
DABCYL analog-coupled uridine proved sluggish.  
An initial attempt to cyclize to the furanouridine using AgNO3 and acetone, conditions 
originally described by Agrofolio79 and previously reported in the Hudson group as successful 
in the synthesis of phenylfuranouridine, 75 was unsuccessful. The starting material was 
reclaimed and the cyclization reaction set up using excess triethylamine, methanol, and CuI. 
After three days at 50ºC and addition of more CuI the starting material was reduced but had not 
disappeared by TLC. Additionally, a new spot appeared by TLC that had a slightly higher RF 
and was slightly deeper red in colour than the spot for the desired product.  
At this time the reaction was stopped and workup proceeded; the furanouridine product was 
isolated via column chromatography, but in moderate yield (44%). Fractions corresponding to 
the new spot were isolated as well, but an 1H NMR spectrum acquired for the resulting solid 
seemed to indicate a mixture of products. This spot likely corresponds to the cis isomer of the 
azo moiety. This isomerization is likely thermally promoted in this instance, as the reaction is 
run under dark conditions. The mixture of product peaks visible by NMR may be a result of the 
cis isomer reverting to the more stable trans isomer under visible light. 
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The next step was one that had proved challenging in previous syntheses: atom exchange via 
aminolysis to convert the furanouridine to pyrrolocytidine. This had been previously 
accomplished by stirring the furanouridine with condensed liquid NH3 and methanol in a 
pressure vessel. 75 However, due to concerns regarding a lack of solubility of the DABCYL 
analog furanouridine in methanol, it was decided to attempt the aminolysis in neat NH3. 
Initially it appeared that the reaction had proceeded, with disappearance of the starting material 
by TLC achieved after overnight reaction at room temperature. However, following 
purification, it appeared by MS that the major product of the reaction had a mass of 795.3729. 
This mass may correspond to this structure, which has the molecular formula C46H46N6O7 and a 
calculated mass of 795.3744: 
 
Figure 24. Proposed structure of major product of aminolysis reaction. The less stable enol 
tautomer is depicted for clarity. 
It would appear that while the ammonia was able to attack and open the furano ring, the lack of 
an additional proton source – normally provided by the methanol – prevented the elimination of 
H2O and the reaction thus stalled.  
Given the small amount recovered of this undesirable product and due to time constraints, it 
was decided to attempt the phosphoramidite synthesis via the cytidine route. 
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3.4 Attempted Synthesis of DABCYL Analogue Pyrrolocytidine 
Phosphoramidite – Cytidine Route 
An advanced cytidine intermediate, courtesy of Dr. Filip Wojciechowski, was located with the 
exocyclic NH3 protected by a benzoyl group and the 5' and 3' hydroxyls bearing tert-butyl 
dimethylsilane (TBDMS) protecting groups. 
 
Scheme 13. Proposed scheme for synthesis of DABCYL pC phosphoramidite V-4 by cytidine 
route. 
In contrast to the uridine route, Sonogashira coupling and cyclization on the protected cytidine 
substrate were accomplished in tandem, with complete conversion of starting material as 
determined by TLC after two days of reaction at 50ºC. Benzoyl deprotection is usually achieved 
in the same pot, but as with the attempted one-pot cyclization of the uridine intermediate, an 
attempt to perform the second reaction without previous purification resulted in an intractable 
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mixture of products. Therefore, it was once again decided to isolate the product of the first step 
of the reaction before attempting the deprotection.  
 
Scheme 14. Revised scheme for benzoyl deprotection to yield compound V-6. 
Following isolation of the benzoyl protected pyrrolocytidine intermediate, benzoyl deprotection 
was achieved by reaction with anhydrous EtOH/triethylamine, followed by removal of the 
TBDMS groups using NEt3 • 3HF to afford the free nucleoside V in good yield (85% over three 
steps). 
The next step was the DMT protection of the nucleoside. Great care was taken during setup of 
the reaction – anhydrous pyridine was further dried over sieves, triethylamine was also dried 
over sieves, and the starting material was coevaporated with pyridine and dried under high 
vacuum to prevent water contamination that could hydrolyze the DMT-Cl tritylating reagent. 
However, the tritylation reaction appeared sluggish, with persistence of starting material by 
TLC following 24 h of reaction. Catalytic AgNO3 and additional DMT-Cl were added to the 
reaction mixture according to a procedure reported by Ogilvie, 80 but this appeared to have no 
effect on the reaction. Finally the reaction was halted. Following basic workup, the product was 
purified by column chromatography in a moderate yield of 50%, but affording an adequate 
amount of product to proceed to the final step in phosphoramidite synthesis.  
1H NMR seemed indicative of formation of the desired product, with the methoxy and aromatic 
peaks appearing in the spectrum with proper integration. Furthermore, the exact mass of the 
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product as measured by MS was very close to the calculated mass (calculated 777.3401; found 
777.3431). 
Synthesis of the phosphoramidite was attempted following conditions previously employed in 
the Hudson group. 75 Once again, synthesis appeared to proceed as usually observed for this 
procedure, with disappearance of starting material in three hours and a new spot appearing by 
TLC. Following purification, the 1H NMR spectrum of the orange solid obtained again 
appeared to correspond to the desired product. However, the 31P NMR spectrum did not show 
the customary pair of singlets in the 130-150 ppm range corresponding to the two diastereomers 
of the phosphoramidite, showing only a broad signal at approximately 138 ppm. It was 
theorized that the broad signal might be a result of the large, “floppy” phosphoramidite 
molecules tumbling slowly in solution, or caused by the presence of cis-trans azo isomers 
complicating the spectrum.  
A MALDI MS spectrum was acquired for compound V-4. While the spectrum was not “clean”, 
a peak was observed at 975.8, close to the expected mass of 975.4. The lack of prominence of 
the peak in the spectrum was attributed to the instability of the phosphoramidite compound in 
the matrix. 
Based on TLC and spectral evidence, it appeared that phosphoramidite V-6 had been 
successfully synthesized. 
3.5 Molecular Beacon Design 
Two oligonucleotide sequences were conceived, again targeting the the Trp1282Ter mutation 
(W1282X) of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. 
Table 2. Proposed molecular beacon oligonucleotide sequences. Q = quencher (compound  
V-4), F = fluorophore (phenyl pC). Vertical lines indicate the probe sequences. 
Name Sequence 
MB-1 5'-Q-G-C-G-A-C-|C-T-T-T-C-C-T-C-C-A-C-T-G-T-|G-T-C-G-C-F-3' 
MB-2 5'-Q-G-C-G-A-G-|G-G-C-T-T-T-C-C-T-C-C-A-C-T-G-T-T-G|-C-T-C-G-C-F-3' 
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The stem sequences were designed based on recommendations for probe design by Dr. Sanjay 
Tyagi81 and examined using the Zuker DNA folding program to verify that they would not be 
likely to form secondary structures that would disrupt stem hybridization. 82 The shorter 
oligonucleotide, MB-1, was designed to hybridize to target sequences already available; as 14 
nucleotides is slightly shorter than the average probe sequence of 15-30 nucleotides, 81 a slightly 
longer probe sequence was envisioned as well (MB-2).  
It remained only to verify the viability of phosphoramidite V-4 to be incorporated into an 
oligonucleotide before synthesis of the full molecular beacon sequences could begin. 
3.6 Attempted Incorporation of Phosphoramidite into DNA 
Oligonucleotide 
To test the coupling efficiency of compound V-6, a T-5 oligonucleotide was synthesized using 
standard phosphoramidite chemistry using commercially available thymidine phosphoramidites 
on an Applied Biosystems International 392 DNA/RNA synthesizer. A manual coupling of 
compound V-4 to this sequence was attempted. MS analysis of the product, however, indicated 
that no coupling had occurred. The synthesis was reattempted and the product examined by MS. 
Once again, only detritylated T-5 DNA was visible by MS. 
Given the complete failure of the phosphoramidite coupling, and due to conflicting spectral 
evidence of product formation, it was decided to attempt a “test phosphitylation” with DMT-
protected thymidine monomer to ensure the viability of the reagents and procedure. The 
reaction was set up using conditions identical to those used in the phosphitylation of compound 
V-3. The reaction was monitored by TLC, using commercially available thymidine 
phosphoramidite as a standard. The starting material appeared to be fully converted to product 
in two hours; following workup and purification conditions identical to those used for the 
DABCYL pC phosphoramidite, a 31P NMR spectrum was acquired for the T phosphoramidite. 
The spectrum contained the expected two strong, sharp singlets at 148 ppm. Furthermore, the 
spectrum contained a singlet near 139 ppm, very close to the broad singlet observed in the 31P 
NMR spectrum of the DABCYL pC phosphoramidite. This suggests that the signal in both 
spectra is caused by an impurity, likely the 2-cyanoethyl methyl diisopropylphosphoramidite 
48 
 
generated by substitution of the chloride for a methoxy group on the phosphoramidite reagent 
during quenching of the reaction with methanol. 
 
Figure 25. Comparison of 31P NMR spectra for DABCYL pC (left) and thymidine (right) 
phosphoramidites. 
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Figure 26 Detail of 31P NMR spectrum of thymidine phosphoramidite showing pair of singlets. 
Given that the reagents and method used for phosphitylation were demostrably viable, it 
appeared that the difficulties met during installation of the phosphoramidite group on 
compound V-4 using identical conditions indicated an intrinsic problem with the DMT-
protected DABCYL pC nucleoside. In order to bypass the need for the phosphoramidite 
derivative, it was decided to directly couple compound V-4 to amine-functionalized controlled 
glass pore (CPG) resin according to a literature procedure. 83  
Loading determination of the resin was attempted by trityl cation assay, but very little orange 
trityl cation was observed in acidic solution, and the loading value determined was extremely 
low – 2 µmol/g instead of the expected 30-40 µmol/g. A deprotection was attempted in neat 
trifluoroacetic acid, again with very little detritylation observable by colour. Samples of resin 
that had been treated with both 3% TCA in DCM and neat TFA were heated in concentrated 
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aqueous ammonia to liberate the nucleoside from the resin. In both cases, examination of the 
cleaved nucleoside by MS indicated that the trityl group was still attached (mass found: 
777.3368. Mass of compound V-3: 777.3431). Given that the trityl group is highly acid labile, 
with deprotection normally occuring in 3% TCA on the order of seconds, this was a puzzling 
result. 
3.7 Addition of Trityl Group to Heterocycle 
The extreme and unexpected stability of the trityl protecting group to acid hydrolysis appeared 
indicative of the formation of a stronger bond during the tritylation reaction – perhaps even a 
carbon-carbon bond. As it turned out, this strange result was not without precedent in the 
Hudson group. A previously synthesized fluorescent pC nucleobase containing a furan ring had 
also resisted DMT deprotection. 
 
Figure 27. Structure of furan-substituted pC VI. 
A closer examination of the 1H NMR spectrum of compound V-3 indicated that the proton 
signal corresponding to H6 was not present. Previously, it had been believed that this signal 
was overlapping with the aromatic proton signals. An HSQC 2D NMR spectrum was acquired 
for compound V-3, but as a correlation could not be positively identified for either the C6 or 
pyrrolo carbons/protons, the result was considered inconclusive.  
The 1H NMR spectrum for compound VI also lacked the H6 proton signal. It would seem in 
both cases that the trityl group had added to C6 of the cytidine ring, likely via electronic 
aromatic substitution (EAS) of the highly electron-rich aromatic system.  
O
OH
HO N
N
O
NH
O
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Scheme 15. Proposed mechanism for the addition of the dimethoxytrityl group to the pC 
heterocycle. 
This would account for the unusual 31P spectrum of the product of the phosphoramidite 
reaction, as the failure to protect the 5' OH group with the DMT group would enable installation 
of the phosphoramidite group at that position, as well as the 3' OH group; this would also 
account for the failure of the DABCYL cytidine “phosphoramidite” to couple with DNA to give 
the desired product. 
An attempt is ongoing to obtain a crystal of compound V-3 to unabiguously determine its 
structure via X-ray crystallography. At any rate, it seemed apparent that synthesis of 
phosphoramidite V-3 cannot be achieved by the conventional cytidine-based pC synthetic route. 
3.8 Conclusion and Outlook 
The unexpected difficulties that arose during synthesis of  DABCYL pC phosphoramidite V-4 
unfortunately precluded incorporation of the compound into DNA and studies into its utility as 
a quencher. However, given the potential demonstrated by the free nucleoside V in quenching 
studies, an alternative synthetic approach is merited. Future work will include a revisiting of the 
uridine route, with improved conditions for the atom exchange/aminolysis reaction, and 
exploration of alternative protecting group strategies for the cytidine route that would permit 
installation of the DMT group before Sonogashira coupling of the DABCYL analog alkyne to 
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iodocytidine/formation of the pC ring. Furthermore, the unprecedented attachment of the DMT 
group to the heterocycle by EAS, which appears to affect a small subset of electron-rich 
pyrrolocytidines, will be the subject of further study. 
3.9 Experimental 
2'-Deoxy-5'-O-(4,4'-dimethoxytrityl)-5-iodouridine (V-1)75 
5-iodouridine (2.124 g, 6 mmol) was dissolved in anhydrous pyridine (45 ml) and Et3N (6 ml) 
was added. The solution was brought to 0ºC. 4,4'-dimethoxytrityl chloride (2.642 g, 7.8 mmol) 
was dissolved in 4 ml anhydrous pyridine. This solution was cooled to 0ºC, then added 
dropwise to the 5-iodouridine solution. The mixture was brought slowly to RT and stirred 
overnight. The reaction mixture was quenched with MeOH (2 ml), then diluted with DCM and 
washed with 0.5 M NaHCO3 (4 x 25 ml). The organic extracts were dried over Na2SO4 and the 
solvent was removed. The residue was purified by FCC eluting with 80:15:5 DCM:Et2O:Et3N 
and the product was isolated as a white foam (1.899 g, 48%). 1H NMR (400 MHz, CDCl3) δ: 
8.13 (s, 1H), 7.44-7.22 (m, 10H), 6.89-6.83 (m, 4H), 6.35-6.30 (m, 1H), 4.57-4.52 (m, 1H), 
4.09-4.06 (m, 1H), 3.46-3.35 (m, 1H), 2.63-2.56 (m, 3H), 2.51-2.44 (m, 1H), 2.35-2.25 (m, 1H). 
– characterization conformed to reported values. 
Sonogashira coupling of DABCYL alkyne 1 to 2'-deoxy-5'-O-(4,4'-dimethoxytrityl)-5-
iodouridine (V-2a) 
2'-Deoxy-5'-O-(4,4'-dimethoxytrityl)-5-iodouridine (0.500 g, 0.8 mmol), and DABCYL analog 
alkyne I (0.299 g, 1.2 mmol) were dissolved in DMF (7 ml) and triethylamine (0.162 g, 1.6 
mmol) was added. The solution was cooled to -78ºC and degassed. Pd(PPh3)4 (0.092 g, 0.08 
mmol) and CuI (0.031 g, 0.16 mmol) were added under N2 and the solution was stirred 
overnight in the dark at RT under a nitrogen atmosphere. The reaction mixture was partitioned 
in DCM/saturated EDTA and the organic phase was washed with sat. EDTA (3 x 25 ml). The 
organic phase was dried with Na2SO4 and solvent was removed. The crude mixture was 
purified by FCC eluting with 80:15:5 DCM:acetone:Et3N to yield compound V-2a as a bright 
orange foam (0.394 g, 63%). 1H NMR (400 MHz, CDCl3) δ: 8.23 (s, 1H) 7.86 (d, J = 8.99 Hz, 
2H) 7.49-7.25 (m, 11H) 7.10-7.20 (m, 3H) 6.71-6.90 (m, 7H) 6.36 (s, 1H) 4.62 (m, 1H) 4.15 
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(m, 1H) 3.8 (m, 1H) 3.70 (d, J = 4.7 Hz, 6H) 3.60 (m, 2H) 3.46 (m, 1H) 3.37 (m, 3H) 3.10 (s, 
6H) 2.54-2.64 (m, 2H) 2.37 (m, 1H). 
Cyclization to furanouridine (V-2) 
Compound 1-2a (0.278 g, 0.4 mmol) was dissolved in DMF (4 ml), Et3N (3 ml), and MeOH (6 
ml). The solution was cooled to -78ºC and degassed. CuI (0.0270 g, 0.14 mmol) was added and 
the solution was degassed again. The mixture was heated to 50ºC and stirred in the dark under a 
nitrogen atmosphere for 72 hrs. Et3N (3 ml) and CuI (0.0270 g, 0.14 mmol) were added and the 
mixture was stirred overnight @ 50ºC in the dark under N2. The mixture was partitioned in 50 
ml DCM/saturated EDTA and washed with sat. EDTA (3 x 50 ml) and brine (1 x 50 ml). The 
organic phase was dried with Na2SO4 and solvent was removed. The mixture was purified by 
FCC eluting with 8.5:1.5:1:0.5 DCM/acetone/hexanes/Et3N to yield an orange solid (0.1209 g, 
44%). 1H NMR (400 MHz, CDCl3) δ: 9.00 (s, 1H) 7.89 (m, 4H) 7.73 (m, 2H) 7.40-7.26 (m, 
11H) 6.86 (m, 4H) 6.78 (m, 2) 6.35 (m, 1H) 5.72 (s, 1H) 4.75 (m, 1H) 4.15 (m, 1H) 3.76 (s, 6H) 
3.61 (m, 3H) 3.11 (m, 5H) 2.76 (m, 1H) 2.50 (m, 1H). 
Aminolysis of compound V-2 
Compound V-2 was placed in a pressure vessel and dissolved in 2-3 ml concentrated liquid 
ammonia. The dark brown mixture was stirred at room temperature overnight. NH3 was 
removed by evaporation at room temperature/atmospheric pressure and the orange solid in the 
pressure vessel was dissolved in minimal DCM and precipitated in hexanes. The solid was 
collected by gravity filtration and solvent was removed under vacuum. The residue was purified 
by FCC (70:20:5:5 DCM/acetone/MeOH/TEA) and the fractions of interest were collected. 
HRMS (ESI): calculated for C46H46N6O7: 795.3744, found: 795.3729.  
Sonogashira coupling of DABCYL analog alkyne 1 to protected iodocytidine II-3 
(compound V-6a) 
Compound V-5 (0.700 g, 1.0 mmol), DABCYL analog alkyne I (0.3812 g, 1.5 mmol), 
Pd(PPH3)4 (0.1156 g, 0.1 mmol), and CuI (0.0190 g, 0.1 mmol) were dissolved in 6 ml fresh 
THF. Et3N (3 ml) was added and the mixture was brought to -78ºC and degassed. The mixture 
was heated to 55ºC and stirred in the dark under N2 for 48 hrs. Partitioned mixture in 
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DCM/saturated EDTA and washed with sat. EDTA (3 x 50 ml). The organic layer was dried 
with Na2SO4 and solvent was removed under vacuum. The residue was subjected to FCC 
(eluent gradient DCM - DCM:MeOH 100-95:5) and solvent was removed from fractions 
containing compound of interest which were then carried forward to benzoyl deprotection.  
Benzoyl Deprotection of Compound V-6a (Compound V-6) 
The residue from the previous reaction was suspended in a mixture of 2:1 anhydrous 
EtOH:Et3N (30 ml). The suspension was heated to 55ºC and stirred under N2 overnight. The 
reaction was stopped and solvent was removed from the mixture under vacuum. The residue 
was subjected to FCC and fractions of interest were isolated and carried forward to the next 
step. 1H NMR (400 MHz, CDCl3) δ: 8.73 (s, 1H) 7.86-7.95 (m, 8H) 6.79 (m, 2H) 6.54 (s, 1H) 
6.45 (m, 1H), 4.43 (m, 1H) 4.09-4.02 (m, 2H) 3.87-3.85 (m, 1H) 3.12 (m, 9H) 1.00 (s, 9H) 0.90 
(s, 10H) 0.08 (m, 6H). 
TBDMS Deprotection of Compound V-6 (Compound V) 
Compound V-6 (0.4226 g, 0.6 mmol) was dissolved in 7 ml THF. The solution was cooled to 
0ºC and Et3N • 3HF (0.2910 g, 1.8 mmol) was added dropwise. The mixture was brought to RT 
and stirred overnight. Solvent was removed and the residue was purified on a short silica gel 
column (90:10 DCM:MeOH) to yield compound V as an orange solid (0.2297 g, 81%). 1H 
NMR (400 MHz, DMSO-d6) δ: 11.89 (br. s., 1H) 8.76 (s, 1H) 7.97 (d, J = 8.6 Hz, 2H) 7.82 (m, 4H) 
6.86 (d, J=9.4 Hz, 2H) 6.26 (m, 1H) 5.17 (s, 1H) 4.26 (m, 1H) 3.92 (m, 1H) 3.65 (m, 2H) 3.07 (s, 
6H) 2.38 (m, 1J) 2.04 (m, 1H). 13C NMR (DMSO-d6) 160.02, 153.80, 152.55, 151.84, 142.70, 
138.64, 136.74, 131.36, 125.78, 124.85, 122.35, 111.56, 109.17, 98.16, 87.93, 87.08, 69.85, 60.93, 
45.66, 41.49.  
Tritylation of Compound V (Compound V-3) 
Compound V (0.1991 g, 0.4 mmol) was suspended in anhydrous pyridine (15 ml) and dry Et3N 
(2.5 ml). The suspension was cooled to 0ºC. 4, 4' dimethoxytrityl chloride (0.1849 g, 0.5 mmol) 
was dissolved in 3 ml anhydrous pyridine and this solution was cooled to 0ºC, then added to the 
previous mixture dropwise via syringe. The mixture was brought slowly to RT and allowed to 
stir under N2 for three days. The reaction mixture was partitioned in DCM/saturated NaHCO3 
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and washed with sat. NaHCO3 (2 x 10 ml) and brine ( 1 x 10 ml). The organic phase was dried 
over Na2SO4, then concentrated and the residue was purified on a short silica gel column (95:5 
DCM:MeOH) to yield an orange solid (0.1509 g, 49%). 1H NMR (DMSO-d6) δ: 11.39 (s, 1H) 
7.78 (d, J = 8.99 Hz, 2H) 7.41 (d, J = 8.21 Hz, 2H) 7.20-6.96 (m, 7H) 6.96 (m, 4H) 6.82 (m, 2H) 
6.09 (m, 1H) 5.24 (m, 1H) 4.66 (m, 1H) 3.91 (m, 1H) 3.69 (m, 1H) 3.59 (s, 6H) 3.06 (m, 9H) 2.20 
(m, 1H) 31C NMR (DMSO-d6) 157.96, 157.47, 153.55, 152.74, 151.13, 145.69, 142.81, 137.46, 
137.21,134.15,131.58, 130.50, 130.14, 127.51, 124.94, 120.79, 117.28, 112.76, 111.76, 110.04, 
87.77, 86.57, 70.92, 62.09, 58.21, 55.01, 40.35, 40.14. HRMS (ESI): calculated for C46H45N6O6: 
777.3401, found: 777.3431. 
Phosphitylation of Compound V-3 (Compound V-34) 
Compound V-3 (0.1000 g, 0.1 mmol) was dissolved in dry DCM (2.5 ml) and dry DIPEA 
(0.0259 g, 0.2 mmol) was added via syringe. 2-cyanoethyldiisopropylphosphoramidite 
(0.0473g, 0.2 mmol) was added dropwise via syringe and the reaction mixture was stirred under 
N2 at RT until TLC indicated consumption of starting material (3.5 hrs). The reaction mixture 
was quenched with 0.2 ml MeOH, partitioned in DCM and saturated NaHCO3, and washed 
with 5 ml saturated NaHCO3 and 5 ml brine. The organic phase was dried over Na2SO4, then 
concentrated. The residue was dissolved in minimal DCM and precipitated from cold hexanes 
to yield an orange solid (0.0951 g, 76%). 1H NMR (DMSO-d6) 11.46 (br s, 1H) 7.79 (m, 2H) 
7.40 (m, 2H) 7.18-6.95 (m, 11H) 6.82 (m, 2H) 6.61 (m, 4H) 6.06 (m, 1H) 4.38-4.17 (m, 2H) 
3.96-3.78 (m, 2H) 3.59 (s, 6H) 3.06 (s, 6H) 2.95 (m, 1H) 2.72 (m, 1H). 
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Chapter 4 – Conclusion and Outlook 
This thesis reports progress toward the synthesis of PNA and DNA molecular beacons, as well 
as fluorophores and quenchers suitable for incorporation into molecular beacons. The first 
portion of the work centered on the development of a novel stepwise synthetic methodology 
that would enable the synthesis of a PNA molecular beacon differentially labeled with a 
fluorophore and a quencher by CuAAC. This synthesis would capitalize on two assets 
previously developed in the Hudson group: the DABCYL analog alkyne, and an Fmoc PNA 
monomer containing an azide group. Three fluoroescent molecules were also derivatized with 
alkyne “handles” for click chemistry via simple, efficient syntheses: 9-aminoacridine, NBD, 
and acridone. While 9-propargylaminoacridine gave disappointing results in terms of 
fluorescence quantum yield, both the NBD and acridone alkynes were demonstrably viable 
fluorophores. Furthermore, a procedure for on-resin click chemistry was evaluated and found to 
be superior to conditions previously employed in the group in terms of efficiency of both 
reaction time and materials used. Unfortunately, technical issues related to PNA peptide 
synthesis deterred progress toward completion of the full molecular beacon; however, the 
groundwork has been laid to proceed with the synthesis once these difficulties have been 
overcome. Synthesis and evaluation of the differentially labeled molecular beacon would 
represent a significant contribution toward the development of a relatively fast and simple 
method for generating molecular beacons which could be used in the detection of genetic 
mutations. In addition, the “clickable” fluorophores themselves could be used for other 
applications, such as the labeling of other biomolecules, notably proteins. 
The second part of the work focuses on the synthesis of a pyrrolocytidine phosphoramidite 
containing a diarylazo moiety that is also analogous to the alkyne quencher DABCYL. The free 
nucleoside had previously been synthesized and its quenching properties determined, with 
encouraging results. Synthetic methodologies for the synthesis of the DABCYL pC 
phosphoramidite were pursued along two different pathways, with uridine and cytidine as 
departure points. The uridine pathway seemed promising, but stalled at the aminolysis step. The 
cytidine pathway enabled arrival at the free nucleoside, but routine protecting group chemistry 
employed in the conversion of the nucleoside to a phosphoramidite resulted in the apparent 
addition of the dimethoxytrityl group to the pC heterocycle by an unanticipated electrophilic 
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aromatic substitution. While the result was not desirable and prevented the incorporation of the 
DABCYL pC nucleoside into a DNA molecular beacon, this side reaction appears to be 
unprecedented and appears to affect a subset of electron-rich pyrrolocytidines that have been 
synthesized in the Hudson group. Thus, the result is intriguing and merits further study. 
Meanwhile, the optimization of synthetic steps along both the uridine and cytidine pathways 
may be valuable in future endeavours to complete synthesis of the DABCYL pC 
phosphoramidite and incorporate it into DNA. Further efforts will likely involve the 
development of alternative protecting group strategies for the cytidine pathway, or optimization 
of the aminolysis step of the uridine pathway. 
In conclusion, this work represents progress toward novel molecular beacon synthetic strategies 
that may in future improve the ease of synthesis of these valuable molecular diagnostic tools. 
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